BioSpace News Archive

Biotech Bay

Scientific Innovation and Collaboration Highlighted at AIDS 2022 as Gilead Extends Leadership Efforts Toward Ending the Global HIV Epidemic

Gilead Sciences, Inc. (Nasdaq: GILD) today announced its upcoming contributions to the 24th International AIDS Conference (AIDS 2022).

July 21, 2022
·
15 min read
Biotech Beach

Evofem Partners with a360 Media to Support Phexxi® Prescription Growth

Evofem Biosciences, Inc., announced an agreement between Evofem and a360 Media under which Phexxi® branded content will appear in some of the most widely read entertainment and lifestyle magazines and websites in the U.S.

July 21, 2022
·
3 min read
BioMidwest

Brand Institute’s President of Canadian Regulatory Affairs Updates Brand Name Assessment Methodology Based on Health Canada Trends

Brand Institute, the global leader in pharmaceutical and healthcare-related name development, is pleased to announce new processes in its workflow.

July 21, 2022
·
2 min read
Business

Prime Therapeutics recognized as a Disability Equality Index® Best Place to Work for Disability Inclusion

Leading pharmacy benefit manager (PBM) Prime Therapeutics LLC (Prime) is proud to announce its score of 90 on the Disability Equality Index ® (DEI), the world’s most comprehensive benchmarking tool measuring workplace inclusion against competitors.

July 21, 2022
·
4 min read
Business

ATEC to Report Second Quarter 2022 Financial Results on August 4, 2022

Alphatec Holdings, Inc. announced today that it will report second quarter 2022 financial results on August 4, 2022, after the market close.

July 21, 2022
·
1 min read
Biotech Bay

InterVenn Expands Global Presence to Drive the Potential of Glycoproteomics to Improve Patient Outcomes

InterVenn Biosciences, a clinical technology company leveraging glycoproteomics to transform the future of healthcare, today announced that it has expanded its global presence with the opening of multiple new locations in Asia-Pacific and North America.

July 21, 2022
·
3 min read
Pharm Country

Synaptogenix Announces Corporate Update Conference Call

Synaptogenix, Inc. today announced that it will hold a corporate update conference call for investors.

July 21, 2022
·
2 min read
Business

Stephen J. Thomas, M.D., Joins Rheonix Board and Executive Team

Rheonix Inc., an innovative leader in highly multiplexed pathogen detection, announced the appointment of Stephen J. Thomas, M.D., as Chief Medical Officer and member of the Rheonix Board of Directors.

July 21, 2022
·
2 min read
North America Dominated the Traumatic Brain Injury Treatment Market and is again Expected to Grow Throughout the Projected Period 2022-2030

The latest market analysis report published by Reports and Data, titled ‘Global Traumatic Brain Injury Treatment Market – Forecast to 2030,’ thoroughly examines the Traumatic Brain Injury Treatment industry to provide essential data & information for the targeted readers.

July 21, 2022
·
5 min read
Revenue Growth of the Pyelonephritis Market is Expected to be Driven by Rising Cases of Urinary Tract Infections and Kidney Infections

The latest market analysis report published by Reports and Data, titled ‘Global Pyelonephritis Market – Forecast to 2030,’ thoroughly examines the Pyelonephritis industry to provide essential data & information for the targeted readers.

July 21, 2022
·
5 min read